Top 10 at 10: Which ASX stocks are on the gain train this morning?

Ok, it’s a bus but train sounds better. Pic: Alan Powdrill / Stone via Getty Images

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.

It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has commenced trading.

WINNERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Code	Company	Price	%	Volume	Market Cap
AMD	Arrow Minerals	0.005	25%	6,882,541	$8,135,060.38
AJQ	Armour Energy Ltd	0.006	20%	1,814,285	$11,292,254.38
ATC	Altech Chem Ltd	0.094	18%	4,161,474	$114,141,269.52
GCR	Golden Cross	0.014	17%	1,012	$13,167,073.32
ROG	Red Sky Energy.	0.007	17%	714,000	$31,813,363.18
BIT	Biotron Limited	0.065	15%	1,635,850	$39,659,198.28
PWR	Peter Warren	2.9	14%	57,187	$436,678,288.44
RDS	Redstone Resources	0.009	13%	125,000	$5,894,659.17
GRX	Greenx Metals Ltd	0.24	12%	155,000	$54,528,399.76
EQN	Equinoxresources	0.165	10%	6,446	$6,750,000.15

Today’s biggest winners include Altech Chemicals (ASX:ATC), who’ve executed a JV agreement with German battery institute Fraunhofer IKTS to commercialise IKTS’ revolutionary CERENERGY Sodium Alumina Solid State (SAS) Battery.

Altech will be the majority owner at 75% of the JV company, which will commercialise a 100 MWh project to be constructed on Altech’s land in Schwarze Pumpe, Germany.

The SAS CERENERGY battery uses common table salt and ceramic solid-state technology, but don’t try making one at home ok.

Also among the winners is Biotron (ASX:BIT) who kicked off a human trial of its lead antiviral drug – BIT225 – against COVID-19 in Thailand.

Apparently the drug has demonstrated both antiviral and favourable immunomodulatory effect in its current development for HIV-1 and has recently demonstrated both antiviral, immune modulatory and clinical benefit against SARS-CoV-2 “in an accepted murine model of disease” which is just a fancy way of saying it’s been tested on mice.

LOSERS

Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Code	Company	Price	%	Volume	Market Cap
DDD	3D Resources Limited	0.001	-33%	15,150,000	$6,647,808.14
RCW	Rightcrowd	0.045	-33%	428,313	$17,530,029.28
CFO	Cfoam Limited	0.004	-20%	300,110	$3,669,203.17
KFE	Kogi Iron Ltd	0.004	-20%	2,060,182	$8,087,888.78
ADY	Admiralty Resources.	0.009	-18%	376,541	$14,339,370.68
DEX	Duke Exploration	0.05	-17%	44,246	$5,457,774.70
AUK	Aumake Limited	0.005	-17%	142,857	$4,628,681.54
MTH	Mithril Resources	0.005	-17%	1,760,000	$17,641,398.25
PBL	Parabellumresources	0.26	-16%	77,465	$12,909,175.31
TON	Triton Min Ltd	0.026	-16%	2,943,268	$39,022,309.49

The biggest loser so far in early morning trade is Duke Exploration (ASX:DEX) who released an update that drilling is expected to be wrapped up at Bundarra this month.

Originally, the plan was to complete follow up resource-style drilling after a data review, but that’s on hold, with DEX citing unfavourable market conditions for small mineral exploration companies at present .

“The company remains confident that the drilling programs completed at Bundarra over recent months will lead to the identification of further resources at the project into the future, but it will require further funding to progress this work,” DEX says.

Small Caps